Vera Therapeutics, Inc. (VERA) insider trading

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Marshall Fordyce

President and CEO

—

$6.39M (14) scheduled

−$6.39M

235,244

0.3264%

$8.70M

+37.7%

William D. Turner

Chief Regulatory Officer

—

$1.45M (4) scheduled

−$1.45M

45,313

0.0629%

$1.68M

—

Joseph R Young

SVP, Finance, Chief Acct Offcr

—

$566.74K (2)

−$566.74K

80,754

0.1121%

$2.99M

+52.0%

Patrick G Enright

Director

$249.99K (1)

—

+$249.99K

3,602,475

5.00%

$133.29M

+7.6%

Sean Grant

Chief Financial Officer

—

$207.78K (1)

−$207.78K

114,181

0.1584%

$4.22M

+69.8%

David Lee Johnson

Chief Operating Officer

—

$108.28K (1)

−$108.28K

45,727

0.0635%

$1.69M

+3,152%

Jason S Carter

Chief Legal Officer

—

$107.50K (1)

−$107.50K

49,136

0.0682%

$1.82M

—

Robert Brenner

Chief Medical Officer

—

$90.31K (1)

−$90.31K

50,947

0.0707%

$1.89M

+4,153%

Laurence Matthew Skelton

Chief Commercial Officer

—

$66.42K (1)

−$66.42K

64,218

0.0891%

$2.38M

+40.2%

Nancy Lee Boman

Chief Regulatory Officer

—

44,987

0.0624%

$1.66M

—

Jane Wright-Mitchell

Chief Legal Officer

—

42,403

0.0588%

$1.57M

—

Vera Therapeutics, Inc.

What the insiders did Net selling

By person